Related Experiment Video

Updated: Jun 10, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Serious infections caused by methicillin-resistant Staphylococcus aureus

Helen Boucher1, Loren G Miller, Raymund R Razonable

  • 1Infectious Diseases Fellowship Program, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|August 25, 2010
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) causes widespread infections. This review covers challenging MRSA infections like bacteremia and osteomyelitis, alongside new treatment options and prevention strategies.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) emerged over 4 decades ago and is now a global threat in healthcare and community settings.
  • Increasing vancomycin resistance in MRSA complicates treatment, necessitating careful consideration of newer agents like daptomycin and linezolid.

Purpose of the Study:

  • To describe clinical features and management of difficult-to-treat MRSA infections, specifically bacteremia/endocarditis and osteomyelitis.
  • To review community-associated MRSA (CA-MRSA) infections.
  • To discuss preventive strategies against MRSA.

Main Methods:

  • Literature review of clinical features and management of MRSA infections.
  • Review of emerging MRSA resistance patterns.
  • Summary of current and novel therapeutic options.
  • Overview of community-acquired MRSA and prevention.

Main Results:

  • MRSA infections, including bacteremia, endocarditis, and osteomyelitis, present significant clinical challenges.
  • Emerging vancomycin resistance necessitates alternative treatment strategies.
  • Newer antibiotics offer expanded therapeutic choices but require complex decision-making.

Conclusions:

  • Effective management of challenging MRSA infections requires a thorough understanding of clinical presentations and evolving resistance.
  • Careful selection of antibiotics, including newer agents, is crucial for successful treatment outcomes.
  • Prevention strategies are essential to curb the spread of MRSA in both hospital and community environments.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...